Related Experiment Video
Updated: Jun 23, 2026

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
Sodium channel mutations and arrhythmias.
Yanfei Ruan1, Nian Liu, Silvia G Priori
1The Leon H. Charney Division of Cardiology, New York University School of Medicine, New York, NY, USA.
Mutations in the SCN5A gene cause various heart rhythm disorders. Understanding these SCN5A gene mutations aids in developing personalized risk stratification and management strategies for inherited arrhythmias.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Electrophysiology
Background:
- The SCN5A gene encodes the alpha subunit of the cardiac sodium channel.
- SCN5A mutations are linked to diverse cardiac rhythm syndromes, including long QT syndrome, Brugada syndrome, and atrial fibrillation.
- Decades of research have elucidated the role of cardiac sodium channels in cardiac health and disease.
Purpose of the Study:
- To review the molecular mechanisms of SCN5A-associated inherited arrhythmias.
- To highlight recent advancements in mutation-specific management for SCN5A-associated long QT syndrome type 3.
- To briefly discuss mutations in cardiac sodium channel beta subunits and associated proteins.
Main Methods:
- Review of clinical evidence and in vitro/in vivo experimental models.
- Analysis of genotype-phenotype correlations in SCN5A-associated arrhythmias.
- Synthesis of current understanding of molecular mechanisms and clinical management strategies.
Main Results:
- SCN5A mutations are implicated in a spectrum of cardiac arrhythmias.
- Established genotype-phenotype correlations inform disease understanding.
- Advances enable the development of gene-specific risk stratification and management.
Conclusions:
- Understanding SCN5A mutations is crucial for diagnosing and managing inherited arrhythmias.
- Mutation-specific strategies are emerging for conditions like long QT syndrome type 3.
- Further research into associated proteins may reveal new therapeutic targets.
More Related Videos
07:15Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Related Concept Videos
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Mechanism of Cardiac Arrhythmias
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...